Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings

Medical and Pediatric Oncology

Volumn 34, Issue 3, 2000, Pages 171-176

  Watanabe, Tsutomu ^a   Kajiume, Teruyuki ^a   Abe, Takanori ^a   Kawano, Yoshifumi ^a   Iwai, Asayuki ^b   Iwai, Tsuyako ^b   Takaue, Yoichi ^c   Kuroda, Yasuhiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b National Hospital Organization   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Allogeneic peripheral blood stem cell transplantation; Hematologic malignancy; HLA matched sibling donor; Pediatric patients

Indexed keywords

BUSULFAN; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INFANT; LEUKEMIA; MALE; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MELPHALAN; NUCLEAR FAMILY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034050443     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200003)34:3<171::AID-MPO2>3.0.CO;2-0     Document Type: Article

References (25)

1. Körbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;83: 1659-1665.
2. Bensinger WI, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancy: a retrospective comparison with marrow transplantation. Blood 1996;88:2794-2800.
3. Schmitz N, Bacigalupo A, Labopin M, et al. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 1996;95:715-723.
4. To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-2258.
5. Glass B, Uharek L, Zeis M, et al. Allogeneic peripheral blood progenitor cell transplantation in a murine model: Evidence for an improved graft-versus-leukemia effect. Blood 1997;90:1694-1700.
6. Zecca M, Perotti C, Marradi P, et al. Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children. Br J Haematol 1996;92:432-434.
7. Diaz MA, Alegre A, Villa M et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with haematological malignancies. Br J Haematol 1997;96:161-164.
8. Li CK, Yuen PMP, Chik KW, et al. Allogeneic peripheral blood stem cell transplant in children. Med Pediatr Oncol 1998;30:147-151.
9. Nussbaumer W, Schonitzer D, Trieb T, et al. Peripheral blood stem cell (PBSC) collection in extremely low-weight infants. Bone Marrow Transplant 1996;18:15-17.
10. Galacki DM. An overview of therapeutic apheresis in pediatrics. J Clin Apheresis 1997;12:1-3.
11. Takaue Y, Kawano Y, Abe T, et al. Collection and transplantation of peripheral blood stem cell in very small children weighing 20 kg or less. Blood 1995;86:372-380.
12. Takaue Y, Watanabe T, Kawano Y, et al. Isolation and storage of peripheral blood hematopoietic stem cells for the autotransplantation in cancer children. Blood 1989;74:1245-1251.
13. Deeg HJ, Cottler-Fox M. Clinical spectrum and pathophysiology of acute graft-versus-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K, editors. Graft-vs-host disease: immunology, pathophysiology, and treatment. New York: Marcel Dekker; 1990. p 311-336.
14. Weite K, Gabrilove J, Bronchud MH, et al. Filgrastim (r-metHuG-CSF): The first 10 years. Blood 1996;88:1907-1929.
15. Anderlini P, Przepiorka D, Champlin R, et al. Biological and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-2825.
16. Goldberg SL, Hangan KF, Klumpp TR, et al. Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses. J Hematother 1995;4:85-90.
17. Diaz MA, Alegre A, Benito A, et al. Peripheral blood progenitor cell collection by large-volume leukapheresis in low-weight children. J Hematother 1998;7:63-68.
18. Pavletic ZS, Bishop MR, Tarantolo SR, et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997;15:1608-1616.
19. Przepiorka D, Anderlini P, Ippoliti C, et al. Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant 1997;19:455-460.
20. Majolino I, Saglio G, Scimè R, et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996;17:555-560.
21. Storek J, Gooley T, Siadak M, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997;90:4705-4709.
22. Miflin G, Russell NH, Hutchinson RM, et al. Allogeneic peripheral blood stem cell transplantation for haematological malignancies - an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant 1997;19:9-13.
23. Rambaldi A, Viero P, Bassan R, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemia. Leukemia 1996;10:860-865.
24. Glass B, Majolino I, Dreger P, et al. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Bone Marrow Transplant 1997;20:533-541.
25. Schmitz N, Bacigalupo A, Hasenclever D, et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: first results of a randomized multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998;21:995-1003.